Ask a doctor about a prescription for MINIMS LIDOCAINE/FLUORESCEIN 40 mg/mL + 2.5 mg/mL EYE DROPS IN SINGLE-DOSE CONTAINERS
Package Leaflet: Information for the User
Minims Lidocaine/Fluorescein40 mg/ml + 2.5mg/ml eye drops, solution in single-dose container
lidocaine hydrochloride/fluorescein sodium
Read this package leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the package leaflet
Minims Lidocaine/Fluorescein eye drops, solution contains a local anesthetic (lidocaine) and a diagnostic agent (fluorescein).
Lidocaine hydrochloride is a local anesthetic that temporarily numbs the surface of the eye. Fluorescein sodium is a temporary dye that helps the doctor or ophthalmologist examine the eyes.
The eye drops are used to:
Possible abrasions on the conjunctiva (the lining of the inside of the eyelids and part of the eye) are stained yellow or orange with fluorescein.
Damage to the cornea (the transparent membrane that covers the surface of the eye) is stained green.
Possible foreign bodies in the eye are surrounded by a green ring.
This medicine is indicated for use in children from 3 years, adolescents, adults, and the elderly.
Do not use Minims Lidocaine/Fluorescein:
Warnings and precautions
Consult your doctor or pharmacist before using this medicine, if:
This eye drop is not intended for prolonged use. Frequent use of local anesthetics in the eye over long periods of time can seriously affect vision.
Anesthetized eyes must be protected from dust and contamination.
Children and adolescents
This medicine is indicated for use in adolescents and children from 3 years.
The product must not be used in children under 3 years.
Other medicines and Minims Lidocaine/Fluorescein
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or ophthalmologist, as they may decide to use this eye drop or prescribe an alternative.
Contact lenses
Your doctor will ask you to remove your contact lenses before administering the eye drops. There is no information on the effect of this product with contact lenses. Therefore, do not put your contact lenses back in until the effects of the eye drops have completely disappeared.
Driving and using machines
As with all eye drops, you may have blurred vision after administration of the drops. Do not drive or use machines until your vision is clear.
Your doctor or ophthalmologist will use this eye drop to examine your eyes.
The eye drop is for single use and is provided in single-dose containers that can be used in both eyes if necessary. Once opened, use immediately. Discard any unused contents.
The normal dose for adults is 1 or 2 drops in one eye or both eyes.
Use in children and adolescents
The doctor or ophthalmologist will decide the suitable dose for adolescents and children over 3 years. Normally, the same dose as for adults is used.
The product must not be used in children under 3 years.
Method of administration
The doctor or ophthalmologist will administer the eye drop into your eye. After administration, a sterile eye drop may be used to remove excess solution. The eye will remain numb for up to 30 minutes. Avoid touching your eye until the anesthetic effect has passed. Your doctor or ophthalmologist will ensure that the eye is properly protected. It is not possible to check the sensitivity of the cornea.
If you use more Minims Lidocaine/Fluorescein than you should
If you use more Minims Lidocaine/Fluorescein eye drops, solution than you should, it is very unlikely that an overdose will occur. If you suddenly feel unwell after administration of the eye drops, inform your doctor or ophthalmologist, or contact the nearest emergency service immediately.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone 91 562 04 20, stating the medicine and the amount ingested.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this eye drop can cause side effects, although not everybody gets them.
The following side effects have been reported very rarely (may affect up to 1 in 10,000 patients):
If after using this eye drop you experience any effect that suggests an allergic reaction, seek medical attention immediately.
In case of worsening of any of the side effects, seek medical attention immediately. If you experience any side effect not listed in this package leaflet, tell your doctor or pharmacist.
Reporting of side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. You can also report them directly to the Spanish Medicines and Healthcare Products Agency (AEMPS) via the website: https://www.notificaram.es/.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the packaging of each single-dose container and on the carton after “EXP”. The expiry date is the last day of the month stated.
Do not store above 25°C. Store in the original packaging to protect from light and moisture loss. Do not freeze. The eye drop is for single use and is provided in single-dose containers that can be used in both eyes if necessary. Once opened, use immediately. Discard any unused contents.
Medicines should not be disposed of via wastewater or household waste. Place the containers and any unused medicines in the SIGRE collection point at your pharmacy. If you are unsure, ask your pharmacist how to dispose of the containers and any unused medicines. This will help protect the environment.
Composition of Minims Lidocaine/Fluorescein
This medicine does not contain preservatives, as it is a sterile single-use unit.
Appearance and packaging
Sterile solution for single use, transparent, yellow in color, reasonably free from visible particles, in a conically-shaped polypropylene container with a twist-and-turn opening mechanism and wrapped in an individual polypropylene/paper bag. Each container holds 0.5 ml of solution. The nozzle of the container is elongated in a dropper shape.
Each carton contains 20 single-dose containers.
Marketing authorization holder and manufacturer
Marketing authorization holder
BAUSCH + LOMB IRELAND LIMITED
3013 Lake Drive
Citywest Business Campus
Dublin 24, D24PPT3
Ireland
Manufacturer
Laboratoire Chauvin
Zone Industrielle de Ripotier, 50 Avenue Jean Monnet
07200, Aubenas
France
You can obtain further information on this medicine by contacting the local representative of the marketing authorization holder.
Local representative in Spain
Bausch & Lomb S.A.
Avda. Valdelaparra, nº 4
28108 Alcobendas
Madrid, Spain
Tel: 91 – 657 63 00
This medicine is authorized in the Member States of the European Economic Area under the following names:
Hungary: Lidocaine/Fluorescein Health-Med 40 mg/ml + 2.5 mg/ml oldatos szemcsepp egyadagos tartályban
Italy: Lidocaina e Fluoresceina Health-Med, 40 mg/ml + 2.5 mg/ml, collirio, soluzione
Malta: Minims Lidocaine & Fluorescein
Portugal: Lidocaína + Fluoresceína Health Med, colírio, solução em recipiente unidose
Spain: Minims Lidocaína/Fluoresceína 40 mg/ml + 2.5 mg/ml colirio en solución en envase unidosis
Greece: Lidocaine & Fluorescein/Health-Med
Cyprus: Lidocaine & Fluorescein Health-Med
Date of last revision of this package leaflet:April 2024
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) https://www.aemps.gob.es/.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for MINIMS LIDOCAINE/FLUORESCEIN 40 mg/mL + 2.5 mg/mL EYE DROPS IN SINGLE-DOSE CONTAINERS – subject to medical assessment and local rules.